The Biotech Trader Handbook and over one million other books are available for Amazon Kindle. Learn more
Buy New
$24.99
Qty:1
  • List Price: $29.95
  • Save: $4.96 (17%)
FREE Shipping on orders over $35.
In Stock.
Ships from and sold by Amazon.com.
Gift-wrap available.
Trade in your item
Get a $2.69
Gift Card.
Have one to sell? Sell on Amazon
Flip to back Flip to front
Listen Playing... Paused   You're listening to a sample of the Audible audio edition.
Learn more
See all 2 images

The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for the non-scientist) Paperback – February 24, 2010


See all 2 formats and editions Hide other formats and editions
Amazon Price New from Used from
Kindle
"Please retry"
Paperback
"Please retry"
$24.99
$24.99 $21.00
Showcase%20Weekly%20Deal


Frequently Bought Together

The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for the non-scientist) + Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes + The Biotech Investor's Bible
Price for all three: $76.25

Buy the selected items together

NO_CONTENT_IN_FEATURE

Image
Looking for the Audiobook Edition?
Tell us that you'd like this title to be produced as an audiobook, and we'll alert our colleagues at Audible.com. If you are the author or rights holder, let Audible help you produce the audiobook: Learn more at ACX.com.

Product Details

  • Paperback: 210 pages
  • Publisher: CreateSpace Independent Publishing Platform; 2 edition (February 24, 2010)
  • Language: English
  • ISBN-10: 1450598536
  • ISBN-13: 978-1450598538
  • Product Dimensions: 9 x 6 x 0.4 inches
  • Shipping Weight: 10.4 ounces (View shipping rates and policies)
  • Average Customer Review: 4.0 out of 5 stars  See all reviews (11 customer reviews)
  • Amazon Best Sellers Rank: #751,862 in Books (See Top 100 in Books)

Editorial Reviews

About the Author

T. Ayers Pelz was a trader on a major European bank's proprietary trading desk. He was responsible for a portfolio with limits of more than $200 million. Prior to proprietary trading, Mr. Pelz worked with several major investment banks in roles ranging from corporate finance, mergers and acquisitions to credit and business development. He has substantial international work experience in Asia, U.S., Europe and Latin America and was based in New York City, Bogotá (Colombia), Rio de Janeiro (Brazil) and Amsterdam (The Netherlands). Mr. Pelz currently resides in Denver, Colorado where he trades for his own account. He is married and has a young son.

More About the Author

Discover books, learn about writers, read author blogs, and more.

Customer Reviews

4.0 out of 5 stars
5 star
7
4 star
1
3 star
1
2 star
0
1 star
2
See all 11 customer reviews
Provides a good overview of how to analyze biotech companies and gives thoughtful ideas on how to trade illiquid options.
Options Trader 109
If you are not a biotech expert but you understand option trading, this book can help you with the missing link you need to achieve real results.
Mister Z
Mr. Pelz has written a fast paced guide to understanding confusing world of Biotech and the very confusing world of options.
VoraciousReader

Most Helpful Customer Reviews

4 of 5 people found the following review helpful By Options Trader 109 on March 5, 2010
Format: Paperback
Kudos to the author of this book. This is the only recently-published book that I have found which targets trading opportunities in biotech. Provides a good overview of how to analyze biotech companies and gives thoughtful ideas on how to trade illiquid options. Also presents several interesting trading strategies. Good addition to any trading library.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
8 of 11 people found the following review helpful By Nakul Nayyar on March 15, 2010
Format: Paperback Verified Purchase
The book seems to be missing some chapters?!?! For example, how exactly to 'handicap' a phase III trial? It goes into no detail on the though process to establish a bullish, bearish, or neutral bias. Although it does clearly explain the ancillary information that might be required in analyzing a biotech company (cash burn, potential value, insider activity, and potential dates) it has no chapter or discussion on how to even begin to determine if a specific drug will pass/fail Phase III trial. Now granted that may be impossible to do in reality with a high degree of probability, but there is not a single case study of a trade to go through the entire process. Also missing is any discussion of how to obtain analysts estimates as a retail trader since most is only available to institutional clients.

That being said the book does do a decent enough job explaining what it does have chapters on including analyzing the cash positions of a firm and creating trading strategies around a specific bias. Unfortunately it never goes into how to exactly establish the bias via explanation or case studies.

Finally the author alludes to many possible potential short term trading opportunities such as a tendency for stocks and volatility around or after a specific announcement, but never elaborates on any. A chapter on this alone would've been worth 10x the price.

Mr Pelz has done a pretty good job with this one but it's only HALF COMPLETE. If the author reads this, please contact me!
1 Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
6 of 9 people found the following review helpful By ntc on January 27, 2012
Format: Paperback
This is not a very helpful book. It seems to be the standard format book written by someone with a website/advisory service. There is a some generic information describing the various steps in drug development as well as the different types of options. Also descriptions of several options strategies. The author does not really make any effort at synthesizing the information into useful conclusions. No real sense of why, when and how to use the different strategies in a biotech setting. This is disappointing, as option approaches can be very useful in this area.

I was also disappointed by the lack of real world examples. The book ends with 2 examples (really - only 2) which are poorly described. Compounding the poor description however, is the fact that they are just fictional constructs. Given how much experience the author apparently has, one would have thought it would be possible to come up with many examples of actual situations that could illustrate his approaches.

I think that someone interested in learning about these methods might be better served by something like The Bible of Options Strategies together with some research on how drug development works (plenty of free resources for this). Then spend some time paper trading strategies to get an understanding for them.
2 Comments Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
2 of 3 people found the following review helpful By Nathan S. Marlar on April 19, 2011
Format: Paperback Verified Purchase
The author is a former bank/prop trader and his experience definitely shows. You're not going to find a bunch of theory and ivory tower ramblings here. Tony takes you from start to finish on how to find and analyze candidates then structure trades based on your outlook. My undergrad is in Intelligence Collection /Operations Planning so I particularly appreciate the way the author breaks down how to sort through the available "intel" from various sources and synthesize an actionable outlook. In this book you are taken from strategic to tactical and back again. This is the kind of book that's needed to be written for a long time. Pick it up and thank me later.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
1 of 2 people found the following review helpful By junkbondtrades on March 9, 2013
Format: Paperback
Active small cap bio stocks trader for years myself, I became %100 better after reading Tony's work.

His stuff simply stands where it's professional enough to contribute and make you more educated and informed, while lightweight enough for you to eat it easily, not getting over complicated - apart for the last part, where you can learn more about option strategies in biotech trading.

So if you want to get yourself more familiar with doing a DD about small cap biotech company, covering the whole story from basic cash position to FDA catalyst and trials, this is definitely the book for you. After reading it you would be able to research yourself and find more accurate and reliable information about your investment.

A final note, I would also recommend this book for beginners as well as more experience traders, as the basics on the book's first chapter includes a precious information, that for a beginner would help to get along better with the subject.

Great work by Tony, I hope he releases another book.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
1 of 2 people found the following review helpful By Thirst for knowledge on September 27, 2012
Format: Paperback Verified Purchase
This book is not very thick, but the author packs into it an extreme amount of valuable data on how to select, time, and invest in biotech stocks. The author shows you specific methods for researching and selecting your biotech investments, without having to have any type of indepth knowledge in the biotech world. He even gives you advice on organizing your research data. The author then goes on in providing different detail methods in evaluating and implementing your investments. The author provides clear cut examples of how to make your biotech investments using options (both puts and calls) and how to hedge your investments to minimize risks while maximizing potential gains.

The author does assume you have an existing knowledge of options, and he tells you this early in the book. If you do not have an indepth knowledge and understand of options and the different option strategies (which I did not) I still highly recommend this book. Then do like I did and find a separate book that simply deals with learning to understand options.

If you are like me though and are thinking about focusing on biotech investing, or perhaps are already investing in biotechs, and want to learn how to improve your results while hedging against the risks... then I highly, highly recommend this book. I definitely feel it is the best investment I have ever made on the subject of investing in biotechs.

One last comment, to those reading my review: I have absolutely no connection with the author, the publisher, or any other associated party related to this book. I am simply an individual investor that was, and is, trying to continue to advance my knowledge and improve my own investing skills. I simply came across this book on Amazon, while looking to see what books were available on biotech investing.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again

Customer Images


What Other Items Do Customers Buy After Viewing This Item?